PGP and hematologic disorder: In conclusion, the path forward involves synergistic efforts across basic science, biomarker discovery, therapeutic innovation, and clinical trial design to ultimately neutralize the impact of P-gp on treatment outcomes in hematological malignancies and improve patient survival and quality of life.